A mysterious surge in shingles cases among millennial women is sending shockwaves through the healthcare community. The condition, previously associated with older age groups, is now affecting younger adults, leaving many to wonder what's behind this unexpected shift. With symptoms ranging from excruciating pain to debilitating rashes, those directly affected are speaking out about their experiences and raising concerns about the implications for public health.
Francine Jones, a 39-year-old healthcare assistant from Hereford, vividly describes her ordeal with shingles: "It was like being struck by lightning – intense, stabbing pain that left me feeling like I was crawling under my own skin." Her testimony is echoed by US research from 2019, which found the sharpest increase in shingles diagnoses between 1998 and 2017 occurred among those aged 30-49, with cases more than doubling in this age group. Although older adults still account for most cases overall, the trend among younger adults is cause for concern.
Shingles, medically known as herpes zoster, occurs when the varicella zoster virus – responsible for chickenpox – reactivates in nerve cells that have been dormant since childhood. The initial symptoms typically involve pain or tingling in a specific skin area, followed by a characteristic blistering rash. According to the NHS, approximately 20% of patients may experience postherpetic neuralgia – persistent pain lasting over 90 days.
Experts are exploring various theories to explain this worrying trend, including increased stress and depression, which can weaken immunity. A US study published in Clinical Infectious Diseases suggests that individuals with certain conditions, such as asthma or diabetes, may have a greater risk of developing shingles if they also experience high levels of stress.
The NHS states that around a quarter of the population will experience shingles at some point in their lives, with incidence typically increasing with age. Currently, the shingles vaccine is offered to those over 65 in the UK. According to data from the Royal College of GPs Research and Surveillance Centre, UK cases are currently above the five-year average. This rise may partly reflect increased diagnoses facilitated by initiatives like Pharmacy First, which allows pharmacists to diagnose and treat a broader range of common conditions.